Injection site reaction to adalimumab: Positive skin test and successful rapid desensitisation

Allergologia et Immunopathologia

Volumn 41, Issue 3, 2013, Pages 204-206

  Bavbek, S ^a   Ataman, S ^a   Bankova, L ^b   Castells, M ^b  

^a ANKARA UNIVERSITY   (Turkey)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; CETIRIZINE; DIPHENHYDRAMINE; FAMOTIDINE; HYDROXYCHLOROQUINE; INFLIXIMAB; METHOTREXATE; SALAZOSULFAPYRIDINE; STEROID;

ADULT; CASE REPORT; CONTROLLED STUDY; DESENSITIZATION; DRUG BLOOD LEVEL; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG SUBSTITUTION; DRUG TOLERABILITY; FEMALE; HUMAN; INJECTION SITE REACTION; INJECTION SITE SWELLING; LETTER; PRURITUS; RHEUMATOID ARTHRITIS; SELF INJECTION; SKIN TEST; STEROID THERAPY; TREATMENT RESPONSE;

ADULT; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DESENSITIZATION, IMMUNOLOGIC; DIPHENHYDRAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ERUPTIONS; ERYTHEMA; FAMOTIDINE; FEMALE; HUMANS; INJECTIONS, SUBCUTANEOUS; INTRADERMAL TESTS; PRURITUS; SKIN TESTS; TIME FACTORS;

EID: 84878106119     PISSN: 03010546     EISSN: 15781267     Source Type: Journal    
DOI: 10.1016/j.aller.2012.04.006     Document Type: Letter

References (10)

1. Lipsky P.E., van der Heijde D.M., St Clair E.W., Furst D.E., Breedveld F.C., Kalden J.R., et al. Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. N Engl J Med 2000, 343:1594-1602.
2. Chen Y.F., Jobanputra P., Barton P., Jowett S., Bryan S., Clark W., et al. A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness. Health Technol Assess 2006, 10:1-229.
3. Benucci M., Manfredi M., Demoly P., Campi P. Injection site reactions to TNF-α blocking agents with positive skin tests. Allergy 2008, 63:138-139.
4. Brennan P.J., Rodriguez Bouza T., Hsu F.I., Sloane D.E., Castells M.C. Hypersensitivity reactions to mAbs: 105 desensitizations in 23 patients, from evaluation to treatment. J Allergy Clin Immunol 2009, 124:1259-1266.
5. Rodriguez Jimenez B., Dominquez-Ortega J. Successful adalimumab desensitization after generalized urticaria and rhinitis. J Investig Allergol Clin Immunol 2009, 19:246-247.
6. Zeltser R., Valle L., Tanck C., Holyst M.M., Ritchlin C., Gaspari A.A. Clinical, histological, and immunophenotypic characteristics of injection site reactions associated with etanercept: a recombinant tumor necrosis factor alpha-receptor: Fc fusion protein. Arch Dermatol 2001, 137:893-899.
7. Winfield H., Lain E., Horn T., Hoskyn J. Eosinophilic cellulites like reaction to subcutaneous etanercept injection. Arch Dermatol 2006, 142:218-220.
8. Paltiel M., Gober L.M., Deng A., Mikdashi J., Alexeeva I., Saini S.S., et al. Immediate type I hypersensitivity response implicated in worsening injection site reactions to adalimumab. Arch Dermatol 2008, 144:1190-1194.
9. Bavbek S., Aydi{dotless}n O., Ataman S., Cahill K., Castells M. Injection-site reaction to etanercept: role of skin test in the diagnosis of such reaction and successful desensitization. Allergy 2011, 66:1256-1257.
10. Quercia O., Emiliani F., Foschi F.G., Stefanini G.F. Adalimumab desensitization after anaphylactic reaction. Ann Allergy Asthma Immunol 2011, 106:547-548.